000 01112 a2200313 4500
005 20250511234722.0
264 0 _c19900629
008 199006s 0 0 hun d
022 _a0030-6002
040 _aNLM
_beng
_cNLM
100 1 _aMüzes, G
245 0 0 _a[Effect of silimarin (Legalon) therapy on the antioxidant defense mechanism and lipid peroxidation in alcoholic liver disease (double blind protocol)].
_h[electronic resource]
260 _bOrvosi hetilap
_cApr 1990
300 _a863-6 p.
_bdigital
500 _aPublication Type: Clinical Trial; Controlled Clinical Trial; English Abstract; Journal Article
650 0 4 _aDouble-Blind Method
650 0 4 _aFlavonoids
_xpharmacology
650 0 4 _aHumans
650 0 4 _aLipid Peroxidation
_xdrug effects
650 0 4 _aLiver Diseases, Alcoholic
_xdrug therapy
650 0 4 _aOxidation-Reduction
_xdrug effects
650 0 4 _aSilymarin
_xpharmacology
700 1 _aDeák, G
700 1 _aLáng, I
700 1 _aNékám, K
700 1 _aNiederland, V
700 1 _aFehér, J
773 0 _tOrvosi hetilap
_gvol. 131
_gno. 16
_gp. 863-6
999 _c2351710
_d2351710